| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |